PDF
ePub
Citation
Print
Abstract
Behçet's disease (BD) is a multisystem disorder presenting recurrent oral and genital ulcerations as well as ocular lesions, involving the nervous system in a subgroup of patients. BD develops at a young age and is frequently presented with an acute or subacute brainstem syndrome or hemiparesis, as well as with other various neurological manifestations, the syndrome is often included in the differential diagnosis of multiple sclerosis, stroke of the young adult, and other neurological disorders. Transverse myelitis (TM) is a clinical syndrome in which an immune-mediated process causes neural injury to the spinal cord, resulting in varying degrees of weakness, sensory alterations and autonomic dysfunction. Spinal Neuro-behcet's disease is rare case. We reported a 33-year old man who had been treated for BD for 3 years.
Figures and Tables
References
1. Cengiz M, Altundag MK, Zorlu AF, Güllü IH, Ozyar E, Atahan IL. Malignancy in Behçet's disease: a report of 13 cases and a review of the literature. Clin Rheumatol. 2001. 20:239–244.
2. Nakae K, Masaki F, Hashimoto T, Inaba G, Mochizuki M, Sakane T. Wechsler B, Godeau P, editors. Recent epidemiological features of Behcet's disease in Japan. Behcet's disease. 1993. Amsterdam: Excerpta Media;145–151.
3. Saruhan-Direskeneli G, Yentür SP, Akman-Demir G, Işik N, Serdaroğlu P. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol. 2003. 145:127–134.
4. Monastero R, Mannino M, Lopez G, Camarda C, Cannizzaro C, Camarda LK, et al. Prevalence of headache in patients with Behçet's disease without overt neurological involvement. Cephalalgia. 2003. 23:105–108.
5. Siva A, Yazıcı H. Levine S, Doruk E, editors. Behçet's disease. Handbook of systemic autoimmune diseases, neurology volume. The neurologic ınvolvement in systemic autoimmune disorders. 2004. New York: Elsevier Science press.
6. Ashjazadeh N, Borhani Haghighi A, Samangooie SH, Moosavi H. Neuro-Behcet's disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behçet's disease in 96 Iranian patients. Exp Mol Pathol. 2003. 74:17–22.
7. Namer IJ, Karabudak R, Zileli T, Ruacan S, Küçükali T, Kansu E. Peripheral nervous system involvement in Behçet's disease. Case report and review of the literature. Eur Neurol. 1987. 26:235–240.
8. Takeuchi A, Kodama M, Takatsu M, Hashimoto T, Miyashita H. Mononeuritis multiplex in incomplete Behçet's disease: a case report and the review of the literature. Clin Rheumatol. 1989. 8:375–380.
9. Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D. Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings. J Neurol. 2002. 249:410–418.
10. Serdaroglu P. Neuromuscular manifestations in the course of Behçet's disease. Acta Myologica. 1998. 2:41–45.
11. Sarui H, Maruyama T, Ito I, Yamakita N, Takeda N, Nose M, et al. Necrotising myositis in Behçet's disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann Rheum Dis. 2002. 61:751–752.
12. Metreau-Vastel J, Mikaeloff Y, Tardieu M, Koné-Paut I, Tran TA. Neurological involvement in paediatric Behçet's disease. Neuropediatrics. 2010. 41:228–234.
13. Tohmé A, Koussa S, Haddad-Zébouni S, El-Rassi B, Ghayad E. Neurological manifestations of Behçet's disease: 22 cases among 170 patients. Presse Med. 2009. 38:701–709.
14. Williams CS, Butler E, Román GC. Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol. 2001. 58:815–819.
15. Calgüneri M, Onat AM, Oztürk MA, Ozçakar L, Ureten K, Akdogan A, et al. Transverse myelitis in a patient with Behçet's disease: favorable outcome with a combination of interferon-alpha. Clin Rheumatol. 2005. 24:64–66.
XML Download